RxDoctor Payments Data

Sree Suryadevara

Colon & Rectal Surgery · Nashville, TNNPI 1952561474

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (50.1%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 91.9% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2019 at $15,732 and has fallen 96.8% since, to $497 in 2025. Among colon & rectal surgery clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,974in general payments, 2019–2025

Across 138 payments — averaging $173.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$22K
  • Braintree Laboratories, Inc.$568
  • Myriad Genetic Laboratories, Inc.$200
  • Conmed Corporation$175
  • Axonics, Inc.$111
  • La Jolla Pharmaceutical Company$98
  • plus $800 from 24 others

What the payments were for

  • Speaking & faculty fees$3,80016%
  • Travel & lodging$3,61315%
  • Food & beverage$4,56219%
  • Education$12,00050%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,974 in reported general payments places this provider in the 95th percentile of 31 colon & rectal surgery providers in Tennessee.

See all colon & rectal surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$116,521
Medicare patients
213
Services billed
641

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SutabSod Sulf/Pot Chloride/Mag Sulf11$1,781
Neomycin Sulfate64$344
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen41$238
Metronidazole71$172

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Braintree Laboratories, Inc.Sutab$568$1,78111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 31 colon & rectal surgery providers in Tennessee.

Other colon & rectal surgery in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →